{
  "DOI": "10.1007/s10689-013-9633-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9633-z",
  "alternative-id": [
    "9633"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Devaud",
      "given": "N.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Gallinger",
      "given": "S.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        3,
        28
      ]
    ],
    "date-time": "2013-03-28T10:41:20Z",
    "timestamp": 1364467280000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        7,
        11
      ]
    ],
    "date-time": "2019-07-11T13:19:13Z",
    "timestamp": 1562851153000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        2,
        11
      ]
    ],
    "date-time": "2023-02-11T09:14:20Z",
    "timestamp": 1676106860507
  },
  "is-referenced-by-count": 41,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2013,
        3,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2013,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            3,
            29
          ]
        ],
        "date-time": "2013-03-29T00:00:00Z",
        "timestamp": 1364515200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9633-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9633-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9633-z",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "301-306",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        3,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        3,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/canjclin.49.1.8",
      "doi-asserted-by": "crossref",
      "key": "9633_CR1",
      "unstructured": "Landis SH et al (1999) Cancer statistics. CA Cancer J Clin 49(1):8–31, 1"
    },
    {
      "DOI": "10.3322/canjclin.35.6.345",
      "doi-asserted-by": "crossref",
      "key": "9633_CR2",
      "unstructured": "Lynch HT (1985) Classics in oncology. Aldred Scott Warthin, M.D., Ph.D (1866–1931). CA Cancer J Clin 35(6):345–347"
    },
    {
      "DOI": "10.1016/0016-5085(93)90368-M",
      "author": "HT Lynch",
      "doi-asserted-by": "crossref",
      "first-page": "1535",
      "issue": "5",
      "journal-title": "Gastroenterology",
      "key": "9633_CR3",
      "unstructured": "Lynch HT et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549",
      "volume": "104",
      "year": "1993"
    },
    {
      "DOI": "10.1016/0092-8674(93)90546-3",
      "author": "R Fishel",
      "doi-asserted-by": "crossref",
      "first-page": "1027",
      "issue": "5",
      "journal-title": "Cell",
      "key": "9633_CR4",
      "unstructured": "Fishel R et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75(5):1027–1038",
      "volume": "75",
      "year": "1993"
    },
    {
      "DOI": "10.1016/0092-8674(93)90330-S",
      "author": "FS Leach",
      "doi-asserted-by": "crossref",
      "first-page": "1215",
      "issue": "6",
      "journal-title": "Cell",
      "key": "9633_CR5",
      "unstructured": "Leach FS et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75(6):1215–1225",
      "volume": "75",
      "year": "1993"
    },
    {
      "DOI": "10.1126/science.8484120",
      "author": "P Peltomaki",
      "doi-asserted-by": "crossref",
      "first-page": "810",
      "issue": "5109",
      "journal-title": "Science",
      "key": "9633_CR6",
      "unstructured": "Peltomaki P et al (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260(5109):810–812",
      "volume": "260",
      "year": "1993"
    },
    {
      "DOI": "10.1126/science.1651563",
      "author": "I Nishisho",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "issue": "5020",
      "journal-title": "Science",
      "key": "9633_CR7",
      "unstructured": "Nishisho I et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253(5020):665–669",
      "volume": "253",
      "year": "1991"
    },
    {
      "author": "R Parsons",
      "first-page": "5548",
      "issue": "23",
      "journal-title": "Cancer Res",
      "key": "9633_CR8",
      "unstructured": "Parsons R et al (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55(23):5548–5550",
      "volume": "55",
      "year": "1995"
    },
    {
      "DOI": "10.1126/science.275.5302.967",
      "author": "N Rampino",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "issue": "5302",
      "journal-title": "Science",
      "key": "9633_CR9",
      "unstructured": "Rampino N et al (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275(5302):967–969",
      "volume": "275",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.2009.27.0652",
      "author": "A Chapelle de la",
      "doi-asserted-by": "crossref",
      "first-page": "3380",
      "issue": "20",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR10",
      "unstructured": "de la Chapelle A, Hampel H (2010) Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 28(20):3380–3387",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.20.4.1043",
      "author": "NM Lindor",
      "doi-asserted-by": "crossref",
      "first-page": "1043",
      "issue": "4",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR11",
      "unstructured": "Lindor NM et al (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20(4):1043–1048",
      "volume": "20",
      "year": "2002"
    },
    {
      "author": "CR Boland",
      "first-page": "5248",
      "issue": "22",
      "journal-title": "Cancer Res",
      "key": "9633_CR12",
      "unstructured": "Boland CR et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58(22):5248–5257",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-0512",
      "author": "JN Poynter",
      "doi-asserted-by": "crossref",
      "first-page": "3208",
      "issue": "11",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9633_CR13",
      "unstructured": "Poynter JN et al (2008) Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev 17(11):3208–3215",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nrclinonc.2009.235",
      "author": "FA Sinicrope",
      "doi-asserted-by": "crossref",
      "first-page": "174",
      "issue": "3",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "9633_CR14",
      "unstructured": "Sinicrope FA (2010) DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat Rev Clin Oncol 7(3):174–177",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1136/gut.42.5.673",
      "author": "JR Jass",
      "doi-asserted-by": "crossref",
      "first-page": "673",
      "issue": "5",
      "journal-title": "Gut",
      "key": "9633_CR15",
      "unstructured": "Jass JR et al (1998) Morphology of sporadic colorectal cancer with DNA replication errors. Gut 42(5):673–679",
      "volume": "42",
      "year": "1998"
    },
    {
      "DOI": "10.1126/science.8484122",
      "author": "SN Thibodeau",
      "doi-asserted-by": "crossref",
      "first-page": "816",
      "issue": "5109",
      "journal-title": "Science",
      "key": "9633_CR16",
      "unstructured": "Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260(5109):816–819",
      "volume": "260",
      "year": "1993"
    },
    {
      "DOI": "10.1200/JCO.2005.03.2433",
      "author": "G Lanza",
      "doi-asserted-by": "crossref",
      "first-page": "2359",
      "issue": "15",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR17",
      "unstructured": "Lanza G et al (2006) Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 24(15):2359–2367",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1053/j.gastro.2006.06.005",
      "author": "FA Sinicrope",
      "doi-asserted-by": "crossref",
      "first-page": "729",
      "issue": "3",
      "journal-title": "Gastroenterology",
      "key": "9633_CR18",
      "unstructured": "Sinicrope FA et al (2006) Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 131(3):729–737",
      "volume": "131",
      "year": "2006"
    },
    {
      "author": "WS Samowitz",
      "first-page": "917",
      "issue": "9",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9633_CR19",
      "unstructured": "Samowitz WS et al (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10(9):917–923",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2005.01.086",
      "author": "S Popat",
      "doi-asserted-by": "crossref",
      "first-page": "609",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR20",
      "unstructured": "Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23(3):609–618",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJM200001133420201",
      "author": "R Gryfe",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "issue": "2",
      "journal-title": "N Engl J Med",
      "key": "9633_CR21",
      "unstructured": "Gryfe R et al (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342(2):69–77",
      "volume": "342",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2010.30.1366",
      "author": "G Hutchins",
      "doi-asserted-by": "crossref",
      "first-page": "1261",
      "issue": "10",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR22",
      "unstructured": "Hutchins G et al (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29(10):1261–1270",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1056/NEJM199002083220602",
      "author": "CG Moertel",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "9633_CR23",
      "unstructured": "Moertel CG et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322(6):352–358",
      "volume": "322",
      "year": "1990"
    },
    {
      "DOI": "10.1200/JCO.1998.16.1.295",
      "author": "MJ O’Connell",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "issue": "1",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR24",
      "unstructured": "O’Connell MJ et al (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16(1):295–300",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.1993.11.10.1879",
      "author": "N Wolmark",
      "doi-asserted-by": "crossref",
      "first-page": "1879",
      "issue": "10",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR25",
      "unstructured": "Wolmark N et al (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11(10):1879–1887",
      "volume": "11",
      "year": "1993"
    },
    {
      "DOI": "10.1200/JCO.1999.17.11.3553",
      "author": "N Wolmark",
      "doi-asserted-by": "crossref",
      "first-page": "3553",
      "issue": "11",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR26",
      "unstructured": "Wolmark N et al (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes’ B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17(11):3553–3559",
      "volume": "17",
      "year": "1999"
    },
    {
      "DOI": "10.1056/NEJMoa032709",
      "author": "T Andre",
      "doi-asserted-by": "crossref",
      "first-page": "2343",
      "issue": "23",
      "journal-title": "N Engl J Med",
      "key": "9633_CR27",
      "unstructured": "Andre T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351",
      "volume": "350",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2006.08.2974",
      "author": "JP Kuebler",
      "doi-asserted-by": "crossref",
      "first-page": "2198",
      "issue": "16",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR28",
      "unstructured": "Kuebler JP et al (2007) Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 25(16):2198–2204",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2008.20.6771",
      "author": "T Andre",
      "doi-asserted-by": "crossref",
      "first-page": "3109",
      "issue": "19",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR29",
      "unstructured": "Andre T et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27(19):3109–3116",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa022289",
      "author": "CM Ribic",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "issue": "3",
      "journal-title": "N Engl J Med",
      "key": "9633_CR30",
      "unstructured": "Ribic CM et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349(3):247–257",
      "volume": "349",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2004.05.063",
      "author": "AB Benson 3rd",
      "doi-asserted-by": "crossref",
      "first-page": "3408",
      "issue": "16",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR31",
      "unstructured": "Benson AB 3rd et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419",
      "volume": "22",
      "year": "2004"
    },
    {
      "DOI": "10.1200/JCO.2006.05.8172",
      "author": "GP Kim",
      "doi-asserted-by": "crossref",
      "first-page": "767",
      "issue": "7",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR32",
      "unstructured": "Kim GP et al (2007) Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 25(7):767–772",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0140-6736(00)02261-3",
      "author": "H Elsaleh",
      "doi-asserted-by": "crossref",
      "first-page": "1745",
      "issue": "9217",
      "journal-title": "Lancet",
      "key": "9633_CR33",
      "unstructured": "Elsaleh H et al (2000) Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355(9217):1745–1750",
      "volume": "355",
      "year": "2000"
    },
    {
      "DOI": "10.1053/gast.2000.18161",
      "author": "A Hemminki",
      "doi-asserted-by": "crossref",
      "first-page": "921",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "9633_CR34",
      "unstructured": "Hemminki A et al (2000) Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 119(4):921–928",
      "volume": "119",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2009.27.1825",
      "author": "DJ Sargent",
      "doi-asserted-by": "crossref",
      "first-page": "3219",
      "issue": "20",
      "journal-title": "J Clin Oncol",
      "key": "9633_CR35",
      "unstructured": "Sargent DJ et al (2010) Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 28(20):3219–3226",
      "volume": "28",
      "year": "2010"
    },
    {
      "author": "M Meyers",
      "first-page": "5193",
      "issue": "13",
      "journal-title": "Cancer Res",
      "key": "9633_CR36",
      "unstructured": "Meyers M et al (2001) Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res 61(13):5193–5201",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ijc.11176",
      "author": "CN Arnold",
      "doi-asserted-by": "crossref",
      "first-page": "66",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "9633_CR37",
      "unstructured": "Arnold CN, Goel A, Boland CR (2003) Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer 106(1):66–73",
      "volume": "106",
      "year": "2003"
    },
    {
      "author": "M Pocard",
      "first-page": "85",
      "issue": "1A",
      "journal-title": "Anticancer Res",
      "key": "9633_CR38",
      "unstructured": "Pocard M et al (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res 20(1A):85–90",
      "volume": "20",
      "year": "2000"
    },
    {
      "DOI": "10.1016/0163-7258(90)90056-8",
      "author": "WB Parker",
      "doi-asserted-by": "crossref",
      "first-page": "381",
      "issue": "3",
      "journal-title": "Pharmacol Ther",
      "key": "9633_CR39",
      "unstructured": "Parker WB, Cheng YC (1990) Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48(3):381–395",
      "volume": "48",
      "year": "1990"
    },
    {
      "author": "A Nehme",
      "first-page": "3253",
      "issue": "15",
      "journal-title": "Cancer Res",
      "key": "9633_CR40",
      "unstructured": "Nehme A et al (1997) Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res 57(15):3253–3257",
      "volume": "57",
      "year": "1997"
    },
    {
      "author": "D Fink",
      "first-page": "1841",
      "issue": "10",
      "journal-title": "Cancer Res",
      "key": "9633_CR41",
      "unstructured": "Fink D et al (1997) In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 57(10):1841–1845",
      "volume": "57",
      "year": "1997"
    },
    {
      "author": "G Guetz des",
      "first-page": "2715",
      "issue": "4C",
      "journal-title": "Anticancer Res",
      "key": "9633_CR42",
      "unstructured": "des Guetz G et al (2007) Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer. Anticancer Res 27(4C):2715–2719",
      "volume": "27",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00280-009-1206-3",
      "author": "ST Kim",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "issue": "4",
      "journal-title": "Cancer Chemother Pharmacol",
      "key": "9633_CR43",
      "unstructured": "Kim ST et al (2010) Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Cancer Chemother Pharmacol 66(4):659–667",
      "volume": "66",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s12032-009-9374-x",
      "author": "ST Kim",
      "doi-asserted-by": "crossref",
      "first-page": "1277",
      "issue": "4",
      "journal-title": "Med Oncol",
      "key": "9633_CR44",
      "unstructured": "Kim ST et al (2010) The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. Med Oncol 27(4):1277–1285",
      "volume": "27",
      "year": "2010"
    },
    {
      "DOI": "10.1093/annonc/mdp383",
      "author": "A Zaanan",
      "doi-asserted-by": "crossref",
      "first-page": "772",
      "issue": "4",
      "journal-title": "Ann Oncol",
      "key": "9633_CR45",
      "unstructured": "Zaanan A et al (2010) Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol 21(4):772–780",
      "volume": "21",
      "year": "2010"
    },
    {
      "author": "S Jacob",
      "first-page": "6555",
      "issue": "17",
      "journal-title": "Cancer Res",
      "key": "9633_CR46",
      "unstructured": "Jacob S et al (2001) The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res 61(17):6555–6562",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ijc.10565",
      "author": "R Magrini",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "9633_CR47",
      "unstructured": "Magrini R et al (2002) Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int J Cancer 101(1):23–31",
      "volume": "101",
      "year": "2002"
    },
    {
      "author": "M Charara",
      "first-page": "3161",
      "issue": "5B",
      "journal-title": "Anticancer Res",
      "key": "9633_CR48",
      "unstructured": "Charara M et al (2004) Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res 24(5B):3161–3167",
      "volume": "24",
      "year": "2004"
    },
    {
      "author": "D Fallik",
      "first-page": "5738",
      "issue": "18",
      "journal-title": "Cancer Res",
      "key": "9633_CR49",
      "unstructured": "Fallik D et al (2003) Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res 63(18):5738–5744",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-2484",
      "author": "F Vincent",
      "doi-asserted-by": "crossref",
      "first-page": "2853",
      "issue": "7",
      "journal-title": "Cancer Res",
      "key": "9633_CR50",
      "unstructured": "Vincent F et al (2009) Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice. Cancer Res 69(7):2853–2860",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.1093/hmg/ddh316",
      "author": "E Bolderson",
      "doi-asserted-by": "crossref",
      "first-page": "2937",
      "issue": "23",
      "journal-title": "Hum Mol Genet",
      "key": "9633_CR51",
      "unstructured": "Bolderson E et al (2004) ATM is required for the cellular response to thymidine induced replication fork stress. Hum Mol Genet 13(23):2937–2945",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1002/emmm.200900040",
      "author": "SA Martin",
      "doi-asserted-by": "crossref",
      "first-page": "323",
      "issue": "6–7",
      "journal-title": "EMBO Mol Med",
      "key": "9633_CR52",
      "unstructured": "Martin SA et al (2009) Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2. EMBO Mol Med 1(6–7):323–337",
      "volume": "1",
      "year": "2009"
    }
  ],
  "reference-count": 52,
  "references-count": 52,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9633-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Chemotherapy of MMR-deficient colorectal cancer"
  ],
  "type": "journal-article",
  "volume": "12"
}